Department of Radiation Oncology, Stanford Cancer Institute, Stanford School of Medicine, Stanford, California.
Department of Otolaryngology Head and Neck Surgery, Stanford School of Medicine, Stanford, California.
Laryngoscope. 2019 Sep;129(9):2082-2086. doi: 10.1002/lary.27753. Epub 2019 Jan 2.
To evaluate the significance of increasing depth of invasion (DOI) as the sole risk factor for recurrence in patients with low-risk early-stage oral cavity squamous cell carcinoma (OCSCC).
We retrospectively reviewed 560 patients with OCSCC treated at our institution between 2003 and 2013. Patients were included if they had low-risk early-stage OCSCC treated with surgical resection ± neck dissection and no adjuvant therapy. Low risk was defined as absence of positive or close margins, lymphovascular invasion, perineural invasion, and positive lymph nodes. Patients with tumor (T)3-T4 disease were excluded. Pathology specimens were independently re-reviewed by two board-certified pathologists to confirm proper measurement of DOI. Kaplan-Meier and Cox proportional hazards regression analyses were performed to identify factors predictive for recurrence as well as progression-free survival (PFS) and overall survival (OS).
A total of 126 patients with low-risk early-stage T1-2N0 OCSCC were included. Median follow-up time was 42.5 months and median DOI was 4 mm. There was no significant difference in incidence of local (P = 0.95), regional (P = 0.81), or distant recurrence (P = 0.96) among patients with DOI < 4 mm versus ≥4 mm. On multivariable analysis, DOI was significant for both PFS (P = 0.03) and OS (P = 0.002).
In this study, we show that in the absence of other high-risk pathologic features, DOI ≥ 4 mm does not portend for increased incidence of local, regional, or distant relapse in patients treated with surgery alone; however, increasing DOI is a marker for worse PFS and OS in patients with low-risk, early-stage OCSCC.
4 Laryngoscope, 129:2082-2086, 2019.
评估浸润深度(DOI)增加作为低危早期口腔鳞状细胞癌(OCSCC)患者复发的唯一危险因素的意义。
我们回顾性分析了 2003 年至 2013 年在我院治疗的 560 例 OCSCC 患者。如果患者接受手术切除±颈清扫术且无辅助治疗,且为低危早期 OCSCC,则纳入研究。低危定义为无阳性或近切缘、脉管侵犯、神经周围侵犯和阳性淋巴结。排除 T3-T4 期肿瘤患者。两名具有董事会认证的病理学家独立重新审查病理标本,以确认正确测量 DOI。进行 Kaplan-Meier 和 Cox 比例风险回归分析,以确定与复发以及无进展生存期(PFS)和总生存期(OS)相关的预测因素。
共纳入 126 例低危早期 T1-2N0 OCSCC 患者。中位随访时间为 42.5 个月,中位 DOI 为 4mm。DOI<4mm 与 DOI≥4mm 的患者局部(P=0.95)、区域(P=0.81)或远处复发的发生率无显著差异。多变量分析显示,DOI 对 PFS(P=0.03)和 OS(P=0.002)均有显著影响。
在本研究中,我们发现,在没有其他高危病理特征的情况下,单独手术治疗时,DOI≥4mm 不会增加局部、区域或远处复发的发生率;然而,在低危早期 OCSCC 患者中,DOI 增加是 PFS 和 OS 较差的标志物。
4 Laryngoscope, 129:2082-2086, 2019.